FH is a genetic condition of very high cholesterol levels that presents a high risk for coronary artery disease.

Rosuvastatin with a 19-h half-life and atorvastatin with an 11–24-h half-life (parent drug and active metabolite) are particularly useful for this approach. Combination therapy with a statin ...

Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...